Story
Chinese Filing Implies AI Startup DeepSeek Valued at Nearly $52 Billion
Summary
A regulatory filing by Anhui Korrun has revealed an indirect investment that places the valuation of low-profile AI startup DeepSeek at approximately $51.82 billion. The disclosure provides a rare public data point on the company's first external fundraising round.
A regulatory filing in China has provided a rare glimpse into the valuation of artificial intelligence startup DeepSeek, implying a valuation of approximately 350.88 billion yuan ($51.82 billion). This figure, disclosed by a publicly-listed company, sheds light on what is believed to be the AI developer's first external fundraising effort.
The Investment Details
According to a stock-exchange filing from Anhui Korrun, a fund in which its subsidiary has invested deployed 2.90 billion yuan to acquire an indirect stake in DeepSeek. The filing specifies that this investment secured an indirect ownership of 0.8265% in the privately held AI company.
This transaction provides a concrete basis for the valuation calculation. The numbers indicate a total valuation for DeepSeek of 350.88 billion yuan. The filing used an exchange rate of $1 to 6.7717 Chinese yuan for its U.S. dollar equivalent of $51.82 billion.
AdContext and Market Significance
The disclosure is significant as it offers the first public evidence of the pricing for DeepSeek's maiden fundraising round. The AI startup, known for being low-profile, has not made any public announcements or detailed its funding activities, making this regulatory filing a key source of information for the market.
This valuation places DeepSeek among the most valuable privately held AI companies globally. For investors and analysts, the figure serves as a crucial benchmark for the broader AI sector in China, highlighting the intense competition and significant capital being allocated to leading players in the race to develop advanced AI models.
Read next
More on Stocks
Telix Pharmaceuticals to Acquire ITM Isotope Technologies for $1.65 Billion
The Australian radiopharmaceutical firm will acquire the German isotope supplier in a deal aimed at vertically integrating its supply chain. The transaction includes $1.25 billion in stock and the assumption of debt.
Jefferies Forecasts S&P 500 to Reach 9,000 by End of 2027 on Earnings Strength
The investment bank set a 2026 year-end target of 8,000 for the index, citing stronger-than-expected corporate earnings and sustained investment in artificial intelligence as key drivers.
S&P 500 Historically Rallies After Midterm Elections, UBS Analysis Shows
U.S. stocks have historically posted strong gains in the months following midterm elections after a period of heightened volatility, according to a research note from UBS.
MOEX Russia Index Closes Flat as Energy Gains Offset Broader Market Declines
Russia's main stock index finished Sunday's session unchanged, as a rally in heavyweight energy stocks like Rosneft masked weakness across the broader market, where declining stocks outnumbered advancers.